Yuen Maggie 4
4 · AtriCure, Inc. · Filed May 20, 2026
Research Summary
AI-generated summary of this filing
AtriCure Director Maggie Yuen Receives Restricted Stock Award
What Happened
- Maggie Yuen, a director of AtriCure, received a restricted stock award of 6,144 shares on May 18, 2026. The shares were granted at $0.00 per share (total reported value $0) as an equity award rather than a purchase or sale.
Key Details
- Transaction date: 2026-05-18; Filing date: 2026-05-20 (Form 4 accession 0001796057-26-000008). Filing appears timely (within the standard two-business-day window).
- Transaction type/code: Award/Grant (A); Price per share: $0.00; Shares acquired: 6,144.
- Shares owned after transaction: Not stated in the provided filing excerpt.
- Footnote: The shares were issued under the AtriCure, Inc. 2023 Stock Incentive Plan and will vest on the one-year anniversary of the grant date (per footnote F1).
Context
- This was a restricted stock grant (compensation), not an open-market purchase or sale. Such awards are common for board compensation and vest over time; they do not by themselves indicate buying or selling intent.
Insider Transaction Report
Form 4
AtriCure, Inc.ATRC
Yuen Maggie
Director
Transactions
- Award
Common Stock
[F1]2026-05-18+6,144→ 17,515 total
Footnotes (1)
- [F1]The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.
Signature
/s/ Allison Walker as Attorney-in-fact for Maggie Yuen|2026-05-20